Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 3;8(10):e10858.
doi: 10.1016/j.heliyon.2022.e10858. eCollection 2022 Oct.

Laboratory detection of SARS-CoV-2: A review of the current literature and future perspectives

Affiliations
Review

Laboratory detection of SARS-CoV-2: A review of the current literature and future perspectives

Kang-Sheng Liu et al. Heliyon. .

Abstract

Nowadays, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), whose infectivity is awfully strong, has been a major global threat to the public health. Since lung is the major target of SARS-CoV-2, the infection can lead to respiratory distress syndrome (RDS), multiple organ failure (MOF), and even death. The studies on viral structure and infection mechanism have found that angiotensin-converting enzyme 2 (ACE2), a pivotal enzyme affecting the organ-targeting in the RAS system, is the receptor of the SARS-CoV-2 virus. Currently, the detection of SARSCoV-2 is mainly achieved using open plate real-time reverse-transcription polymerase chain reaction (RT-PCR). While open plate method has some limitations, such as a high false-negative rate, cumbersome manual operation, aerosol pollution and leakage risks. Therefore, a convenient method to rapidly detect SARS-CoV-2 virus is urgently and extremely required for timely epidemic control with the limited resources. In this review, the current real-time methods and principles for novel coronavirus detection are summarized, with the aim to provide a reference for real-time screening of coronavirus in areas with insufficient detection capacity and inadequate medical resources. The development and establishment of a rapid, simple, sensitive and specific system to detect SARS-CoV-2 is of vital importance for distinct diagnosis and effective treatment of the virus, especially in the flu season.

Keywords: Gene editing techniques; Gene sequencing; Novel coronavirus; Nucleic acid testing; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic diagram of interaction between SPIKE protein and ACE2 protein. The virus is able to specifically recognize ACE2 on the membrane of host cell through the S protein on its surface, achieves the fusion of virus and host cell membrane and then enters the host cell.
Figure 2
Figure 2
Schematic diagram of LAMP technique. The LAMP method does not rely on an accurate temperature circulation system; thus, the amplification time of nucleic acid is shortened. The advantages of LAMP technology enable rapid detection and diagnosis of COVID-19, as well as a large-scale detection ①- ⑥: Initial procedures to form dumbbell-like structure. : amplification of LAMP (Bao et al., 2020; Obande and Singh, 2020).
Figure 3
Figure 3
The illustration of SHERLOCK principle (Bao et al., 2020).
Figure 4
Figure 4
The illustration of DETECTR detection principle (Bao et al., 2020).

Similar articles

Cited by

References

    1. Ackerman C.M., Myhrvold C., Thakku S.G., Freije C.A., Metsky H.C., Yang D.K., et al. Massively multiplexed nucleic acid detection using Cas13. Nature. 2020;582:277. - PMC - PubMed
    1. Arumugam A., Faron M.L., Yu P., Markham C., Wu M., Wong S. A rapid SARS-CoV-2 RT- PCR assay for low resource settings. Diagnostics. 2020;10:739. - PMC - PubMed
    1. Bao Y.F., Xue Q.R., Wu H.P., Zou B., Song Q.X., Zhou G.H. Vol. 51. 2020. Advances in point-of-care Testing for New corona Virus Nucleic acid. J. China Pharm. Univ. pp. 635–645.
    1. Broughton J.P., Deng X., Yu G., Fasching C.L., Servellita V., Singh J., et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat. Biotechnol. 2020;38:870‒874. - PMC - PubMed
    1. Chen J.S., Ma E., Harrington L.B., Da Costa M., Tian X., Palefsky J.M., et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018;360:436–439. - PMC - PubMed

LinkOut - more resources